Literature DB >> 25786592

Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab.

Michelangelo Vestita1, Stefania Guida1, Stella Mazzoccoli1, Francesco Loconsole1, Caterina Foti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25786592     DOI： 10.1684/ejd.2015.2526

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  2 in total

1.  Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.

Authors:  Claudio Marasca; Giuseppina Fontanella; Maria C Annunziata; Dario Marasca; Gabriella Fabbrocini
Journal:  Int Wound J       Date:  2019-04-01       Impact factor: 3.315

Review 2.  Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.

Authors:  Anastasia Skalkou; Sofia-Magdalini Manoli; Alexandros Sachinidis; Vasilios Ntouros; Konstantinos Petidis; Eleni Pagkopoulou; Efstratios Vakirlis; Athina Pyrpasopoulou; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2017-10-26       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.